Hematologic Malignancies

Proposal & Budget Guidelines

Gilead Research Scholars Gilead Research Scholars
  • Available Programs
  • Login / Register
Gilead Research Scholars
  • Program Overview
    • Scientific Focus
    • Scientific Review Committee
    • Eligibility
    • Criteria For Selection
  • Application Information
    • Proposal & Budget Guidelines
    • Program Timeline
    • Inquiries/Contact Information
    • Downloads
  • Applications
  • Award Recipients
  • Contact
  • FAQ

Application Information

Kite and Gilead Sciences Research Scholars Program in Hematologic Malignancies

The Research Proposal should be a clear and concise presentation of the applicant's proposed research.

The Proposal must include:

Research Abstract

Provide an abstract of no more than 325 words outlining the applicant's proposed research.

Research Proposal

Proposal must be single-spaced (using 11 point Arial font or larger) and limited to 5 pages total, not including the bibliography or budget. Research proposals over 5 pages will not be accepted. Please include your bibliography with the research proposal, but do not count those pages in the 5-page limitation.

The proposal must include:

  1. Title of the proposed research
  2. Description of research objectives, including relevant literature, specific aims, study design, methodology, data, and projected results
  3. Discussion of the relevance of the proposed research to the objectives of the program. Refer to the Scientific Focus section of this website.
  4. Description of analytical methods (figures and tables should be included in the body of the text, where applicable)
  5. Description of potential research challenges and possible approaches for overcoming them
  6. Description of relevant past work by the applicant, including joint collaborations and references

Budget Guidelines

Each selected awardee is funded up to $130,000 USD (inclusive of any indirect costs), to be paid in two annual instalments of up to $65,000 USD per year directly to the researcher's institution. Funding for the second year is contingent upon submission of a progress report by each junior faculty researcher and approval by the Chair of the Scientific Review Committee.

An itemized budget must be submitted with the proposal, consistent with the following guidelines:

Indirect Costs:

  • In order to maximize the research benefit of the award, the program encourages that every effort be made to minimize the utilization of the award to cover indirect costs. If required, up to 10% of the award can be directed to indirect costs. 

Salaries:

  • The applicant may allocate up to $50,000 USD per year in salary and fringe benefits support for the applicant and/or a technician
  • Salaries and fringe benefits for mentors, post-doctoral fellows, or students may not be included

Supplies:

  • Supplies such as disposables, chemicals, reagent kits, animals, etc, may be included
  • Equipment purchases with a single item value of greater than $2,500 USD may not be included

Travel:

  • Up to $1,500 USD per year for applicant's travel to a scientific meeting for presentation of project data may be included

Human and Animal Studies

If the research project includes investigations on human subjects, a copy of the submission to the institutional review board (IRB) must be submitted prior to award. Award will be contingent upon IRB approval.

If the research project involves laboratory animals, researcher must certify that he/she will comply with all laws and regulations pertaining to care and use of animals in research prior to award.

 

  • GILEAD and the GILEAD logo are registered
  • trademarks of Gilead Sciences, Inc., or one of its related companies. Kite
  • and the Kite Logo are registered trademarks of Kite, a Gilead company.
  • © 2022 Gilead Sciences, Inc. All rights reserved.
  • Proposal & Budget Guidelines
  • Program Timeline
  • Inquiries/Contact Information
  • Downloads

GILEAD and the GILEAD logo are registered trademarks of Gilead Sciences, Inc., or one of its related companies.

© 2020 Gilead Sciences, Inc. All rights reserved. 

Privacy Policy 

Terms of Use 

Funding Considerations